QIAGEN’s QuantiFERON-TB Gold Plus gains approval in Japan
Qiagen N.V. Common Shares (QGEN)
Last qiagen n.v. common shares earnings: 2/4 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
corporate.qiagen.com/investor-relations
Company Research
Source: Business Wire
Unique immune detection technology and flexible workflow for tuberculosis control efforts HILDEN, Germany & TOKYO--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection. QFT-Plus is the fourth generation of QIAGEN’s market-leading QuantiFERON-TB technology, combining innovative CD4+/CD8+ design for comprehensive immune response detection with the most flexible blood collection workflow for efficient screening in large-scale TB control programs. “QuantiFERON-TB Gold Plus sets a new global standard for latent TB testing. The proprietary CD4+/CD8+ T cell technology of QFT-Plus, with the addition of specific CD8+T cell stimulating antigens, has the potential to provide important insights for high-risk p
Show less
Read more
Impact Snapshot
Event Time:
QGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QGEN alerts
High impacting Qiagen N.V. Common Shares news events
Weekly update
A roundup of the hottest topics
QGEN
News
- U.S. Next Generation Sequencing Market Analysis Report 2024-2030: Consumables Dominated the Product Segment in 2023, Owing to the Increasing Demand for High-quality and Reliable Sequencing Products [Yahoo! Finance]Yahoo! Finance
- Global Infectious Disease In vitro Diagnostics Analysis Report 2024: An $80+ Billion Market in 2030 - Investment in Education and Training and Leveraging Artificial Intelligence for Advancements [Yahoo! Finance]Yahoo! Finance
- Exploring New Horizons: BCC Research Forecasts $5.2 Billion Global Induced Pluripotent Stem Cells Market by 2028 [Yahoo! Finance]Yahoo! Finance
- Global Protein Expression Market Outlook 2024-2034: North America and APAC Set for Rapid Expansion [Yahoo! Finance]Yahoo! Finance
- QIAGEN N.V. to release results for Q1 2024 and hold webcast [Yahoo! Finance]Yahoo! Finance
QGEN
Earnings
- 2/6/24 - Miss
QGEN
Sec Filings
- 3/11/24 - Form 20-F
- 3/11/24 - Form IRANNOTICE
- 2/9/24 - Form SC
- QGEN's page on the SEC website